|
000
| 01402nam 2200301zi 4500 |
|---|
| 001 | 9.903387 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107180232 |
|---|
| 006 | m o d f |
|---|
| 007 | cr ||||||||||| |
|---|
| 008 | 210917s2021 oncd os f000 0 eng d |
|---|
| 020 | |a9780660403670 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP40-297/2021E-PDF |
|---|
| 245 | 00|aTrends in HIV pre-exposure prophylaxis use : |ban analysis of prescription data in eight Canadian provinces, 2016-2020. |
|---|
| 264 | 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |c[2021] |
|---|
| 300 | |a1 online resource (1 unnumbered page) : |bcolour graphs |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Utilisation de la prophylaxie préexposition au VIH (PPrE) : une analyse des données de prescription dans huit provinces canadiennes, 2016-2020. |
|---|
| 650 | 0|aHIV infections|zCanada|xPrevention. |
|---|
| 650 | 0|aPre-exposure prophylaxis|zCanada|vStatistics. |
|---|
| 655 | 7|aStatistics|2lcgft |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tUtilisation de la prophylaxie préexposition au VIH (PPrE) : |w(CaOODSP)9.903389 |
|---|
| 856 | 40|qPDF|s476 KB|uhttps://publications.gc.ca/collections/collection_2022/aspc-phac/HP40-297-2021-eng.pdf |
|---|